Skip to main content
SpringerLink
Log in

Tetrofosmin: mit 99mTechnetium markierbares Radiopharmakon als Perfusionsmarker für die Myokardszintigraphie

  • Chapter
Single-Photon-Emissions-Computertomographie (SPECT) des Herzens

  • 47 Accesses

Zusammenfassung

Seit der Entdeckung von 201Thallium (201Tl) als Perfusionsmarker des Myokards [1] hat sich die Myokardszintigraphie zu einer Routinediagnostik für den Nachweis von Durchblutungsstörungen des Herzmuskels entwickelt. Zunächst als planare Technik in 3 Ebenen (1. anteriore, 2.45°–60° links anteriore und 3.70°–90°links laterale Sicht) entwickelt mit der Darstellung von inferiorer Wand, Apex und anterolateraler Wand in der 1. Sicht, des Septums, der inferoapikalen Wand und der Posterolateralwand in der 2. Sicht sowie der anterioren Wand, des Apex, der inferioren und posterioren Wand in der 3. Sicht, verbreitete sich mit der Tomographietechnik die Single-Photon-Emissions-Computertomographie (SPECT) als Methode der Wahl zur Bestimmung der Myokardperfusion [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Strauss HW, Harrison K, Langan JK, Lebowitz E, Pitt B (1975) Thallium-201 for myocardial imaging:relation of thallium-201 to regional myocardial perfusion. Circulation 51: 641–645.

    PubMed  CAS  Google Scholar 

  2. Kaul S (1989) A look at 15 years of planar thallium-201 imaging. Am Heart 118: 581–601.

    Google Scholar 

  3. Fletcher GF, Froelicher VF, Hartley H, Haskell WL, Pollock ml (1990) Exercise standards: a statement for health professionals from the American Heart Association. Circulation 82: 2286–2321.

    Article  PubMed  CAS  Google Scholar 

  4. Dilsizian V, Bonow RO (1993) Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation 87: 2–20.

    Google Scholar 

  5. Simon J, Ketring A, Troutner DE, Volkert WA, Holmes RA (1979) Labelling of a macrocyclic tetraaza ligand with technetium-99m. Radiochem Radioanal Lett 38:133–141.

    CAS  Google Scholar 

  6. Deutsch E, Glavan KA, Ferguson DL, Lukes SJ, Nishiyama H, Sodd VJ (1980) Development of a Tc-99m myocardial imaging agent to replace Tl-201. J Nucl Med 21: 56 (Abstract).

    Google Scholar 

  7. Deutsch E, Glavan KA, Sodd VJ, Nishiyama H, Ferguson DL, Lukes SJ (1981) Cationic Tc-99m complexes as potential myocardial imaging agents. J Nucl Med 22: 897–907.

    PubMed  CAS  Google Scholar 

  8. Deutsch E, Ketring AR, Libson K, Vanderheyden J-L, Hürth WJ (1989) The Noah’s ark experiment: species dependent biodistribution of cationic 99mTc complexes. Int J Rad Appi Instrum (B) 16:191–232.

    CAS  Google Scholar 

  9. Holman BL, Jones AG, Lister-James J et al. (1984) A new Tc-99m-labeled myocardial imaging agent, hexakis(t-butylisonitrile)technetium-(I)(Tc-99m-TBI): initial experience in the human. J Nucl Med 25:1350–1355.

    PubMed  CAS  Google Scholar 

  10. Dean RT, Wester DW, Nosco DL et al. (1986) Progress in the design, evaluation and development of Tc-99m radiopharmaceuticals. In: Nicolini M, Bandoli G, Mazzi U (eds) Technetium in chemistry and nuclear medicine. Raven, New York, pp 147–154.

    Google Scholar 

  11. Wester DW, White DH, Miller FW, Dean RT (1984) Synthesis and characterization of a technetium-phosphite complex: hexakis(trimethyl-phsphite-technetium(I) teraphenylborate. Inorg Chem 23:1501–1502.

    Article  CAS  Google Scholar 

  12. Wackers FJT, Berman DS, Maddahi J et al. (1989) Technetium-99m hexakis 2- methoxyisobu-tyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 myocardial perfusion imaging. J Nucl Med 30: 301–311.

    PubMed  CAS  Google Scholar 

  13. Leppo JA, DePuey EG, Johnson LL (1991) A review of cardiac imaging with sestamibi and teboroxime. J Nucl Med 32: 2012–2022.

    PubMed  CAS  Google Scholar 

  14. Kelly JD, Forster AM, Higley B et al. (1993) Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med 34: 222–227.

    PubMed  CAS  Google Scholar 

  15. Platts EA, North TL, Pickett RD, Kelly JD (1995) Mechanism of uptake of technetium-tetro-fosmin.I: Uptake into isolated adult rat ventricular myocytes and subcellular localization. J Nucl Cardiol 2: 317–326.

    Article  PubMed  CAS  Google Scholar 

  16. Younes A, Songadele JA, Maublant J, Platts E, Pickett R, Veyre A (1995) Mechanism of uptake of technetium-tetrofosmin.II: Uptake into isolated adult rat heart mitochondria J Nucl Cardiol 2: 327–333.

    Google Scholar 

  17. Dahlberg ST, Gilmore MP, Leppo JA (1992) Effect of coronary blood flow on the “uptak” of tetrofosmin in the isolated rabbit heart. J Nucl Med 33 (5 Suppl): 846 (Abstract).

    Google Scholar 

  18. Higley B, Smith FW, Smith T et al. (1993) Technetium-99m-i,2-bis(bis(2-ethoxyethyl)phos-phino)ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 34: 30–38.

    PubMed  CAS  Google Scholar 

  19. Jain D, Wackers FJT, Matterà J, McMahon M, Sinusas AJ, Zaret BL (1993) Biokinetics of tech-netium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol. J Nucl Med 34:1254–1259.

    PubMed  CAS  Google Scholar 

  20. Sridhara BS, Braat S, Rigo P, Itti R, Cload P, Lahiri A (1993) Comparison of myocardial perfusion imaging with technetium-99m tetrofosmin versus thallium-201 in coronary artery disease. Am J Cardiol 72:1015–1019.

    Article  PubMed  CAS  Google Scholar 

  21. Zaret BL, Rigo P, Wackers FJT et al. (1995) Myocardial perfusion imaging with 99mTc tetrofosmin: comparison to 201T1 imaging and coronary angiography in a phase III multicenter trial. Circulation 91: 313–319.

    PubMed  CAS  Google Scholar 

  22. Stiehr Th (1995) Diagnostische Relevanz verschiedener Myokard - SPECT - Techniken. Med Diss, Univ Tübingen.

    Google Scholar 

  23. Irmer M, Reuland P, Huonker M, Berg A, Keul J (1996) Combined physical and pharmacological stress for diagnosis of coronary heart disease. Comparison of stress-echo and myocardial scintigraphy. Cardiovasc Imag 8:87.

    Google Scholar 

  24. Ignaszewski A, McCormick L, Heslip P, McEwan A, Humen DP (1993) Safety and clinical utility of combined intravenous dipyridamole/symptom limited exercise stress test with thallium-201 imaging in patients with known or suspected coronary artery disease. J Nucl Med 34: 2053–2061.

    PubMed  CAS  Google Scholar 

  25. Marwick Th, Namec JJ, Paschkow FJ et al. (1992) Accuracy and limitations of exercise echocardiography in a routine clinical setting. J Am Coll Cardiol 19:7.

    Article  Google Scholar 

Download references

Authors
  1. P. Reuland
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Bundeswehrzentralkrankenhaus Koblenz, Rübenacher Straße 170, 56072, Koblenz, Germany

    Helmut J. Wieler (Leitender Arzt der Abt. Nuklearmendizin) (Leitender Arzt der Abt. Nuklearmendizin)

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Reuland, P. (1997). Tetrofosmin: mit 99mTechnetium markierbares Radiopharmakon als Perfusionsmarker für die Myokardszintigraphie. In: Wieler, H.J. (eds) Single-Photon-Emissions-Computertomographie (SPECT) des Herzens. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60621-2_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60621-2_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64479-5

  • Online ISBN: 978-3-642-60621-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation